Elevate Now Raises Rs 18 Cr in Seed Round Led by Physis Capital

Why It Matters

The infusion of capital positions Elevate Now to scale its medically supervised, data‑driven weight‑loss model, challenging traditional diet apps and attracting health‑focused investors. This could accelerate adoption of personalized, non‑surgical obesity treatments in India’s fast‑growing digital health market.

Key Takeaways

• Raised Rs 18 crore seed round led by Physis Capital.
• Total funding now exceeds $2 million plus Rs 18 crore.
• Platform targets root-cause weight loss with medical supervision.
• 30,000+ paying users, average 10 kg loss in six months.
• Revenue grew 17% month‑on‑month Apr 2025‑Jan 2026.

Pulse Analysis

The global obesity epidemic has turned weight management into one of the most lucrative segments of digital health. In India, rising disposable incomes and increasing awareness of metabolic diseases have spurred a wave of tech‑enabled solutions, from calorie‑counting apps to tele‑medicine platforms. Investors are keen to back models that combine clinical expertise with scalable software, as they promise higher patient adherence and better health outcomes. Against this backdrop, Elevate Now’s recent seed raise reflects broader confidence in medically supervised, data‑rich weight‑loss services.

Elevate Now differentiates itself by targeting the root causes of weight gain—insulin resistance, inflammation and hormonal imbalance—rather than relying solely on calorie restriction. Each subscriber receives a physician‑led treatment plan, continuous glucose monitoring, blood diagnostics and a dedicated health coach, all delivered through a subscription‑based, fully online interface. The Rs 18 crore infusion will fund enhancements to its AI‑driven personalization engine, expand proprietary clinical trials, and accelerate the development of proprietary supplements. These upgrades aim to improve efficacy at scale and deepen the platform’s clinical credibility.

The capital boost positions Elevate Now to compete more aggressively with established players such as HealthifyMe, SugarFit and Fittr, which largely focus on lifestyle coaching. By embedding medical supervision and evidence‑based interventions, the startup can capture a higher‑value segment of consumers willing to pay for clinically validated results. If the company sustains its reported 17% month‑on‑month revenue growth, it could set a new benchmark for subscription‑based obesity care in emerging markets, prompting further consolidation and innovation across the digital health ecosystem.